Table 3.
Comparison of the laboratory results between athletes with concordant abnormal ET and MPS results and the matched individuals with low-to-intermediate risk of CAD
| Athletes (N = 9) | Controls (N = 9) | p-value | |
|---|---|---|---|
| CRP (mg/l ± SD) | 0.9 ± 0.7 | 0.8 ± 0.6 | 0.624 |
| Leukocyte count (x10^9/l ± SD) | 5.5 ± 1.3 | 7 ± 0.7 | 0.013 |
| Creatinine clearance (ml/min/1.7 ± SD) | 57.1 ± 4.9 | >60 ± 0.0 | 0.116 |
| Glucose (mmol/l ± SD) | 5.5 ± 0.8 | 5.5 ± 0.5 | 0.859 |
| Total cholesterol (mmol/l ± SD) | 4.8 ± 0.4 | 4.8 ± 0.6 | 0.962 |
| Triglyceride (mmol/l ± SD) | 1.1 ± 0.4 | 2.0 ± 1.4 | 0.103 |
| HDL (mmol/l ± SD) | 1.6 ± 0.4 | 1.4 ± 0.4 | 0.423 |
| Chol/HDL ratio | 3.2 ± 0.7 | 3.7 ± 1.3 | 0.383 |
| LDL (mmol/l ± SD) | 2.8 ± 0.4 | 2.5 ± 0.4 | 0.192 |
| ET‑1 (pg/ml ± SD) | 1.3 ± 0.2 | 1.0 ± 0.2 | 0.012 |
ET exercise test, MPS myocardial perfusion scintigraphy, CAD coronary artery disease, SD standard deviation, CRP C-reactive protein, HDL high-density lipoprotein cholesterol, LDL low-density lipoprotein cholesterol, ET‑1 endothelin‑1